EUVIMEDEUVIMED entdecken
Crossref

Enhanced diagnosis accuracy of tuberculous meningitis using mycolic and tuberculostearic acid via advanced mass spectrometry

Mridu Singh, Vikram Singh, Juhi Verma, Manish Raj Kulshrestha, Vandana Tiwari, Tushant Kumar, Jaya Garg

Journal of the Neurological Sciences · 2025

DOI: 10.1016/j.jns.2025.123748 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Neurological Sciences, 2025. Verfasst von Mridu Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, Mycolic Acids. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Dr Ram Manohar Lohia Institute of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tuberculous meningitis (TBM) remains challenging to diagnoses, especially in resource-limited settings. This study assessed the diagnostic utility of cerebrospinal fluid (CSF) biomarkers, mycolic acid (MA) and tuberculostearic acid (TBSA) in diagnosing TBM, comparing their performance against microbiological confirmation and Marais scoring system. METHODS: This was a tertiary hospital-based prospective study conducted on (n = 172) meningitis who were classified into the definite TBM, probable TBM, possible TBM, and non TBM groups, based on microbiological gold standards and the Marais scoring system. CSF parameters, including glucose, protein, white blood cell (WBC) count, and adenosine deaminase (ADA) levels, were measured. MA and TBSA biomarker levels were quantified by tandem mass spectrometry. Diagnostic performance was evaluated based on sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the receiver operating characteristic curve (AUC) by comparing between definite TBM and non TBM categories. RESULTS: Definite TBM exhibited the lowest CSF glucose and highest WBC and ADA levels. Protein content was also the highest among the probable and definite categories. MA demonstrated excellent diagnostic performance with a sensitivity of 93.1 %, specificity of 100 %, PPV of 100 %, and NPV of 94.7 % (AUC = 0.96). TBSA showed slightly lower sensitivity (82.8 %), but high specificity (94.4 %), with a PPV of 92.3 % and NPV of 87.2 % (AUC = 0.97). Among the indeterminate cases, both MA and TBSA showed higher positivity in the probable TBM group and minimal positivity in the non TBM group, highlighting their high specificity. CONCLUSION: MA and TBSA are highly sensitive and specific biomarkers for the diagnosis of TBM. These biomarkers, in conjunction with clinical parameters, may offer significant diagnostic value for enhancing TBM diagnosis as depicted in our results on comparison between definite and non-TBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, MeningealMycolic AcidsHumansMaleFemaleAdultProspective StudiesMiddle AgedBiomarkersSensitivity and SpecificityYoung AdultAgedAdolescentTandem Mass Spectrometry

Stichwörter der Autor:innen

Cerebrospinal fluidDiagnostic biomarkersMass spectrometryMycolic acidTuberculostearic acidTuberculous meningitis

Substanzen

Mycolic AcidsBiomarkers

Autor:innen und Institutionen

  • Department of Medicine, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
  • Department of Biochemistry, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
  • Department of Biochemistry, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. Electronic address: drmrkul@gmail.com.
  • Department of Radiodiagnosis, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
  • Department of Microbiology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Förderung

  • Dr Ram Manohar Lohia Institute of Medical Sciences

Zitieren

APA

Singh, M., Singh, V., Verma, J., Kulshrestha, M. R., Tiwari, V., Kumar, T., & Garg, J. (2025). Enhanced diagnosis accuracy of tuberculous meningitis using mycolic and tuberculostearic acid via advanced mass spectrometry. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2025.123748

Vancouver

Singh M, Singh V, Verma J, Kulshrestha MR, Tiwari V, Kumar T, et al. Enhanced diagnosis accuracy of tuberculous meningitis using mycolic and tuberculostearic acid via advanced mass spectrometry. Journal of the Neurological Sciences. 2025. doi:10.1016/j.jns.2025.123748

BibTeX
@article{Singh2025,
  author = {Singh, Mridu and Singh, Vikram and Verma, Juhi and Kulshrestha, Manish Raj and Tiwari, Vandana and Kumar, Tushant and Garg, Jaya},
  title = {Enhanced diagnosis accuracy of tuberculous meningitis using mycolic and tuberculostearic acid via advanced mass spectrometry},
  journal = {Journal of the Neurological Sciences},
  year = {2025},
  doi = {10.1016/j.jns.2025.123748}
}
Kostenlos starten →